Dual diagnosis treatment for Jupiter — one team, both diagnoses, together.

For families in Abacoa, Tequesta, or Jupiter Inlet Colony, RECO Health's Delray Beach campus is 32 miles south on I-95 — about 45 minutes outside of rush. Dual diagnosis clients see the same in-house addiction psychiatrist for MAT (buprenorphine, naltrexone, acamprosate) and psychotropic medication, and a therapist trained in both addiction and trauma delivers the CPT, EMDR, or Prolonged Exposure that drives the co-occurring diagnosis. One team, one problem list, both diagnoses on the same plan — not two providers passing charts.

From Jupiter, RECO Health’s Delray Beach campus is 32 miles south on I-95 — about 45 minutes outside of rush hour. For families in Abacoa, Tequesta, or Jupiter Inlet Colony, that distance is short enough to sustain an intensive outpatient schedule two or three days a week and long enough that the Delray campus offers meaningful separation from the neighborhoods, workplaces, and social contacts tied to active use when partial hospitalization is the appropriate level of care. For clients presenting with co-occurring substance use and psychiatric illness, that geographic buffer is often what decides whether the first two weeks of treatment take.

Why sequential treatment fails for co-occurring disorders

The evidence on sequential treatment — the older “get sober first, then we’ll deal with the mental health” model — is unambiguous. Clients treated for substance use disorder without concurrent attention to depression, PTSD, or bipolar illness relapse earlier and more often than clients whose diagnoses are addressed together. The untreated diagnosis destabilizes the treated one: depression that isn’t managed during addiction treatment produces the anhedonia and hopelessness that drive early return-to-use, and active substance use during a depression trial blunts SSRI response and confounds the clinical picture. That relapse trajectory is well-documented in the addiction literature and predates the current dual diagnosis framework by decades.

Integrated treatment is the standard of care articulated by SAMHSA and the American Psychiatric Association, and it is not a scheduling artifact. It requires clinical staff cross-trained in addiction medicine and psychiatry, a shared treatment plan reviewed by the full team, and case conceptualization that treats both diagnoses as primary. Dual diagnosis treatment at RECO Health is built around that clinical reality: one psychiatrist, one primary therapist, one team, both diagnoses on the same plan.

The high-prevalence co-occurring diagnoses

Five psychiatric conditions account for most of the co-occurring diagnostic load in a substance use population: major depressive disorder, PTSD, generalized anxiety disorder, bipolar disorder, and adult ADHD. RECO screens for all five at intake with validated instruments — PHQ-9 for depressive symptom severity, PCL-5 for PTSD, GAD-7 for anxiety, MDQ for bipolar screening, and ASRS for adult ADHD. Screening scores do not diagnose; they scaffold the psychiatric interview and identify what warrants longitudinal assessment.

Each diagnosis has a defined evidence-based pathway inside the program. Depression is treated with an SSRI or SNRI — sertraline, escitalopram, or duloxetine are common first-line choices — paired with CBT and behavioral activation. PTSD is treated with a trauma-focused protocol (Cognitive Processing Therapy, Prolonged Exposure, or EMDR) once initial stabilization is complete. Bipolar disorder is managed with a mood stabilizer regimen — lithium, lamotrigine, or an atypical antipsychotic such as quetiapine or aripiprazole — before any antidepressant is considered. ADHD is treated with a non-stimulant such as atomoxetine or guanfacine when substance use history contraindicates stimulants, or with a carefully monitored stimulant trial when it does not.

MAT and psychotropic medication managed by one psychiatrist

One of the most common relapse pathways in dual diagnosis clients is fragmented prescribing. A primary care doctor manages the antidepressant, an outside psychiatrist manages the mood stabilizer, and an MAT provider manages the buprenorphine or naltrexone — with none of the three seeing the full medication list, and none catching the interactions or the dose that has quietly stopped working. Clients relapse into a gap the system created.

At RECO, MAT and psychotropic medication are prescribed by the same in-house addiction psychiatrist. Buprenorphine or extended-release naltrexone for opioid use disorder, naltrexone or acamprosate for alcohol use disorder, and the client’s antidepressant, mood stabilizer, or ADHD medication are managed under one problem list. Interactions are considered — sertraline plus tramadol, buprenorphine plus benzodiazepines, lithium plus NSAIDs — and dosing is coordinated with the client’s therapy schedule and level of care. When adjunctive interventions such as ketamine, esketamine, or rTMS at 120% of motor threshold for 3000 pulses per session are appropriate for treatment-resistant depression, the same psychiatrist selects and titrates against the addiction picture, not around it.

Trauma is often the through-line

For a substantial share of dual diagnosis clients, unprocessed trauma is upstream of both the substance use and the mood disorder. The client presents for alcohol or opioid treatment; the depression looks like a consequence of the addiction; and the actual driver — a sexual assault, a combat exposure, a childhood of chronic neglect — is disclosed in the third or fourth week of care, or not at all. Treatment plans that ignore the trauma treat the surface and miss the mechanism.

RECO’s protocol screens for trauma at intake with the Life Events Checklist and PCL-5, stabilizes early with grounding, distress tolerance, and DBT skills, and moves into evidence-based trauma processing — CPT, PE, or EMDR — once the client’s window of tolerance supports it. Doing trauma work too early destabilizes; doing it too late lets the substance use recur as a coping mechanism the moment discharge removes the structure. Sequencing is a clinical judgment made by a therapist trained in both trauma and addiction, not a program milestone the calendar advances.

What to expect on the first visit

The first day at RECO is an integrated intake: biopsychosocial assessment, psychiatric evaluation, medical clearance, and level-of-care determination against the six ASAM Criteria dimensions — withdrawal risk, biomedical conditions, emotional/behavioral/cognitive conditions, readiness to change, relapse potential, and recovery environment. Withdrawal severity is scored with CIWA-Ar for alcohol and COWS for opioids, and benzodiazepine tapers, when indicated, are planned against a specific timeline rather than adjusted reactively. When medically supervised withdrawal management is required, the client is admitted to the detox unit the same day; when it is not, IOP or PHP can be started within 48-72 hours.

The psychiatric evaluation covers current diagnoses, medication history, prior treatment response, and any suicidality or safety concerns using the C-SSRS. The output of the first day is a written, individualized treatment plan that names the target diagnoses, the modalities that will be used, and the reviewing clinician. Family members from Jupiter are typically invited into the process within the first week with the client’s written consent.

Insurance and admissions from Jupiter

RECO Health is in-network with most major commercial insurers used by Palm Beach County families, including Florida Blue, Aetna, Cigna, UnitedHealthcare, Humana, and BCBS plans. Benefits verification is completed before admission, and when a plan requires prior authorization the admissions team obtains it rather than leaving the client to navigate the payer. Out-of-pocket estimates — deductible, coinsurance, and any per-diem — are written down and reviewed before the client commits to a level of care.

Admissions from Jupiter can typically be scheduled within the same week. For clients arriving from Admirals Cove, Jonathan’s Landing, or Tequesta, transportation to the Delray campus can be arranged; for clients driving themselves, the route is a straight 32-mile run south on I-95 to the Linton Boulevard corridor. Level of care — detox, residential, PHP, or IOP — is set by clinical criteria at intake, not by insurance default, and any step-down forced by coverage limits is documented so the client and family can weigh the clinical trade-off.

Serving residents of: Abacoa, Jupiter Inlet Colony, Tequesta, Admirals Cove, Jonathan's Landing.